Technical Articles
KRAS G12V & SOS1 Binding Kit (GDP load)
Application of KRAS G12V & SOS1 Binding Assay Kit in T Cell Recognition Mechanism Research
The KRAS G12V mutation is one of the most common driver mutations in refractory tumors such as pancreatic cancer and lung cancer. Due to the intracellular localization of the KRAS protein, traditional antibody drugs struggle to directly target it, making this target a long-standing therapeutic challenge.
View details
- Drug Research
- KRAS G12V & SOS1 Binding Kit (GDP load)
- Pancreatic cancer
- Lung cancer
- 1












